These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22486719)

  • 1. Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis.
    Bouazza N; Pestre V; Jullien V; Curis E; Urien S; Salmon D; Tréluyer JM
    Br J Clin Pharmacol; 2012 Dec; 74(6):971-7. PubMed ID: 22486719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dramatic reduction of clindamycin serum concentration in staphylococcal osteoarticular infection patients treated with the oral clindamycin-rifampicin combination.
    Bernard A; Kermarrec G; Parize P; Caruba T; Bouvet A; Mainardi JL; Sabatier B; Nich C
    J Infect; 2015 Aug; 71(2):200-6. PubMed ID: 25936632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections.
    Curis E; Pestre V; Jullien V; Eyrolle L; Archambeau D; Morand P; Gatin L; Karoubi M; Pinar N; Dumaine V; Nguyen Van JC; Babinet A; Anract P; Salmon D
    Infection; 2015 Aug; 43(4):473-81. PubMed ID: 25837442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs.
    Batzias GC; Delis GA; Athanasiou LV
    Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the clindamycin administration route on the magnitude of clindamycin-rifampicin interaction: a prospective pharmacokinetic study.
    Zeller V; Magreault S; Heym B; Salmon D; Kitzis MD; Billaud E; Marmor S; Jannot AS; Salomon L; Jullien V
    Clin Microbiol Infect; 2021 Dec; 27(12):1857.e1-1857.e7. PubMed ID: 33915288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin.
    O'Reilly T; Kunz S; Sande E; Zak O; Sande MA; Täuber MG
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2693-7. PubMed ID: 1336342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability.
    Yang SH; Lee MG
    Int J Pharm; 2007 Mar; 332(1-2):17-23. PubMed ID: 17157458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of clindamycin hydrochloride in homogenates of normal dog skin when administered at two oral dosage regimens.
    Saridomichelakis MN; Athanasiou LV; Chatzis MK; Salame M; Katsoudas V; Pappas IS
    Vet Q; 2013; 33(1):7-12. PubMed ID: 23445168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of gender in the oral pharmacokinetics of clindamycin in humans.
    del Carmen Carrasco-Portugal M; Luján M; Flores-Murrieta FJ
    Biopharm Drug Dispos; 2008 Oct; 29(7):427-30. PubMed ID: 18623043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of rifampicin in adult patients with osteoarticular infections: interaction with fusidic acid.
    Marsot A; Ménard A; Dupouey J; Muziotti C; Guilhaumou R; Blin O
    Br J Clin Pharmacol; 2017 May; 83(5):1039-1047. PubMed ID: 27813241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of clindamycin HCl administered intravenously, intramuscularly and subcutaneously to dogs.
    Lavy E; Ziv G; Shem-Tov M; Glickman A; Dey A
    J Vet Pharmacol Ther; 1999 Aug; 22(4):261-5. PubMed ID: 10499238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in postantibiotic effect of clindamycin against clinical isolates of Staphylococcus aureus and implications for dosing of patients with osteomyelitis.
    Xue IB; Davey PG; Phillips G
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1403-7. PubMed ID: 8726009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous clindamycin infusion, an innovative approach to treating bone and joint infections.
    Zeller V; Dzeing-Ella A; Kitzis MD; Ziza JM; Mamoudy P; Desplaces N
    Antimicrob Agents Chemother; 2010 Jan; 54(1):88-92. PubMed ID: 19841148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients.
    Delaunay J; Villani AP; Guillem P; Tristan A; Boibieux A; Jullien D
    Br J Dermatol; 2018 Jan; 178(1):e15-e16. PubMed ID: 28626900
    [No Abstract]   [Full Text] [Related]  

  • 15. An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations.
    Levinson RS; Mitan SJ; Steinmetz JI; Gattermeir DJ; Schumacher RJ; Joffrion JL
    Clin Ther; 2005 Dec; 27(12):1894-900. PubMed ID: 16507375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption of clindamycin after intravaginal application of clindamycin phosphate 2% cream.
    Borin MT; Powley GW; Tackwell KR; Batts DH
    J Antimicrob Chemother; 1995 Jun; 35(6):833-41. PubMed ID: 7559194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits.
    Shirtliff ME; Mader JT; Calhoun J
    Clin Orthop Relat Res; 1999 Feb; (359):229-36. PubMed ID: 10078148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of bioavailabilities and pharmacokinetics of clindamycin in healthy volunteers and patients with AIDS.
    Gatti G; Flaherty J; Bubp J; White J; Borin M; Gambertoglio J
    Antimicrob Agents Chemother; 1993 May; 37(5):1137-43. PubMed ID: 8517703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability and selected pharmacokinetic parameters of clindamycin hydrochloride after administration of a new 600 mg tablet formulation.
    Mazur D; Schug BS; Evers G; Larsimont V; Fieger-Büschges H; Gimbel W; Keilbach-Bermann A; Blume HH
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):386-92. PubMed ID: 10475141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
    Wilhelm AJ; de Graaf P; Veldkamp AI; Janssen JJ; Huijgens PC; Swart EL
    Br J Clin Pharmacol; 2012 Apr; 73(4):553-63. PubMed ID: 21988410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.